Sppi stock zacks
Spectrum Pharmaceuticals (NASDAQ:SPPI) Rating Increased to ... Zacks Investment Research upgraded shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) from a sell rating to a hold rating in a report issued on Tuesday morning, Zacks.com reports. The brokerage currently has $1.75 price target on the biotechnology company’s stock. According to Zacks, “Spectrum Pharma reported dismal fourth-quarter results, wherein earnings and revenues missed estimates. The What Awaits Spectrum Pharmaceuticals (SPPI) In Q4 Earnings ... Investors are likely to focus on updates related to Spectrum Pharmaceuticals, Inc.'s (NASDAQ: SPPI) commercialization plan for Rolontis, following a potential approval, on fourth-quarter earnings Is the Options Market Predicting a Spike in Spectrum ... Oct 23, 2019 · Investors in Spectrum Pharmaceuticals, Inc. SPPI need to pay close attention to the stock based on moves in the options market lately. That is because … Spectrum Pharmaceuticals, Inc. (SPPI) stock forum ...
Spectrum Pharmaceuticals News | Markets Insider
Oct 23, 2019 · Investors in Spectrum Pharmaceuticals, Inc. SPPI need to pay close attention to the stock based on moves in the options market lately. That is because … Spectrum Pharmaceuticals, Inc. (SPPI) stock forum ... Find the latest Spectrum Pharmaceuticals, Inc. (SPPI) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. SPPI Price Target - ETF Channel The median SPPI price target (a different metric than the average or mean) was $11.0 as of 2020-02-08, the highest SPPI price target in the range was $13.0 while the lowest SPPI price target in the range was $3.5, with a standard deviation of $4.415. Get the latest Zacks research report on SPPI — FREE. 10 ETFs With Most Upside To Analyst Targets Spectrum Pharma: 4Q Earnings Snapshot HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Thursday reported a loss of $39.1 million in its fourth quarter. On a per-share basis, the Henderson, Nevada-based company said it had a loss of 35 cents. Losses, adjusted for one-time gains and costs, came to 30 cents per share.
Options Traders Expect Huge Moves in Spectrum ...
Jan 01, 2010 · Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance SPPI - Spectrum Pharma News - Barchart.com Spectrum Pharma Inc (SPPI) Spectrum Pharma Inc (SPPI) (SPPI) Stock Zacks Equity Research - Zacks Investment Research - Wed Nov 27, 7:44AM CST. Wed Nov 27, 7:44AM CST. Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock … Spectrum Pharmaceuticals, Inc. (SPPI): Zacks Rank Buy Jul 14, 2011 · Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI - News) has been a big winner in 2011, recently hitting a new all-time high after reporting strong Q1 …
SPPI - Spectrum Pharmaceuticals, Inc. Summary, Stock Quote ...
SPPI Spectrum Pharmaceuticals, Inc. — Stock Price and ... Real-time trade and investing ideas on Spectrum Pharmaceuticals, Inc. SPPI from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. SPPI Stock Quote - Spectrum Pharmaceuticals, Inc.Common ... Stock quote for Spectrum Pharmaceuticals, Inc.Common Stock Common Stock (SPPI) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Spectrum Pharmaceuticals Stock Quote: SPPI Stock News ...
Spectrum Pharmaceuticals Stock Quote: SPPI Stock News ...
Spectrum Pharmaceuticals (SPPI) Stock Sinks As Market ... Jan 17, 2020 · Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Spectrum Pharmaceuticals, Inc. (SPPI) : Free Stock Analysis Report To read this article on Zacks.com click here. ETFs Holding SPPI | Spectrum Pharmaceuticals Inc | ETF Channel SPPI Description — Spectrum Pharmaceuticals Inc. Spectrum Pharmaceuticals is a biopharma company. Co.'s commercialized products include: FOLOTYN, a folate analogue metabolic inhibitor for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL); BELEODAQ, a histone deacytelase inhibitor for the treatment of patients with relapsed or Spectrum Pharma: 4Q Earnings Snapshot - SFChronicle.com Feb 27, 2020 · HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Thursday reported a loss of $39.1 million in its fourth quarter. On a per-share … NASDAQ:SPPI / Spectrum Pharmaceuticals, Inc. - Stock Price ...
Find the latest Spectrum Pharmaceuticals, Inc. (SPPI) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. SPPI Price Target - ETF Channel The median SPPI price target (a different metric than the average or mean) was $11.0 as of 2020-02-08, the highest SPPI price target in the range was $13.0 while the lowest SPPI price target in the range was $3.5, with a standard deviation of $4.415. Get the latest Zacks research report on SPPI — FREE. 10 ETFs With Most Upside To Analyst Targets Spectrum Pharma: 4Q Earnings Snapshot HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Thursday reported a loss of $39.1 million in its fourth quarter. On a per-share basis, the Henderson, Nevada-based company said it had a loss of 35 cents. Losses, adjusted for one-time gains and costs, came to 30 cents per share.